Emily Hutton-Steel

Emily Hutton-Steel has a strong background in clinical research and project management within various therapeutic areas. With experience at companies like Indivior, Opiant Pharmaceuticals, and BioMarin Pharmaceutical Inc., Emily has led global clinical studies and managed cross-functional teams. Their responsibilities have included overseeing clinical trials in areas such as opioid & alcohol use disorders, rare diseases, infectious diseases, and oncology. With a degree in Pharmacology from the University of Glasgow, Emily has successfully managed projects from early phase studies to phase IIIB/IV trials.